CommercialCoverageMedium impact
06.02.54d, Cobalamin (Vitamin B12), Folic Acid, and Homocysteine Testing
Independence Blue Cross·Family Medicine, Internal Medicine, Endocrinology +2 more·Medical Policy
Effective date
Oct 1, 2025
We identified it
Jun 19, 2026
Summary
Independence Blue Cross updated their medical policy for Cobalamin (Vitamin B12), Folic Acid, and Homocysteine Testing effective October 1, 2025. This policy change may affect coverage criteria, prior authorization requirements, or billing procedures for these laboratory tests.
Action Required
By October 1, 2025: Billing team must review the complete policy at https://medpolicy.ibx.com/ibc/Commercial/Pages/Site-Activity-View.aspx to understand specific changes to coverage criteria for Vitamin B12, Folic Acid, and Homocysteine testing. Update billing procedures and prior authorization workflows as needed based on the detailed policy requirements.